Cargando…
Role of central and peripheral neuropeptides in escitalopram-induced weight gain and metabolic changes
INTRODUCTION: Selective serotonin reuptake inhibitors (SSRI group antidepressant drugs) are not significantly different from tricyclic antidepressants and other antidepressants in terms of efficacy, but provide significant advantages in terms of side effects and toxicity. One of the most important s...
Autor principal: | Yilmaz, M. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434339/ http://dx.doi.org/10.1192/j.eurpsy.2023.1040 |
Ejemplares similares
-
Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021) -
Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022) -
Weight gain and metabolic disorders induced by psychotropic drugs: an appraisal of risk factors
por: Eap, C. B.
Publicado: (2023) -
Mydriasis caused by ESCITALOPRAM: A case report
por: Bouattour, N., et al.
Publicado: (2023) -
PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)